Mode
Text Size
Log in / Sign up
N/A N=4 Treatment

Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration

Periodontal Diseases

Enrolled (actual)
4
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcome: Primary: Probing Depth Change — 4.22 millimeter

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Amnion-Chorion allograft membrane on the root surface of periodontally diseased site. (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Indiana University
Primary completion
Sep 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Probing Depth Change
4.22
PRIMARY
Clinical Attachment Change
2.44

Summary

The purpose of this pilot project is to evaluate the efficacy of application of Amnion-Chorion allograft membrane on the root surface of periodontally diseased teeth in conjunction with bone substitute covered by Amnion-Chorion allograft in a combination Guided Tissue Regeneration (GTR) treatment of periodontal intrabony and furcation defects.

Eligibility Criteria

Inclusion Criteria

  • ASA class I or II;
  • age >18 years old;
  • Non-smoker;
  • diagnosis of chronic or aggressive periodontitis previously treated with nonsurgical mechanical debridement; 5) patients have at least one two-wall intrabony defect in interproximal areas with radiographic evidence of an intrabony component of ≥ 4 mm, PPD ≥ 6 mm with 1-wall or 2-wall or combination of those defects;
  • Glickman Grade II furcation involvement on buccal of mandibular or maxillary first or second molars without soft tissue exposure of furcation entrance; 7) tooth mobility Miller Grade <1; 8) more than 2mm of keratinized tissue with those selected teeth.

Exclusion Criteria

  • did not meet all inclusion criteria;
  • pregnancy or nursing woman;
  • subjects with active systemic or localized infection (exclude chronic periodontitis);
  • poor compliance or failure to maintain good oral hygiene as ascertained by the presence of full-mouth plaque score ≥ 20%;
  • restorations or caries on root surfaces or untreated endodontic infections;
  • participants received periodontal surgical treatment on the same site of this study within 2 years;
  • use of systemic or local antibiotics on the anticipated surgical sites during the past 3 months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03095976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search